Blood transfusion and risk of infection in frail elderly after hip fracture surgery: the TRIFE randomized controlled trial

Eur J Orthop Surg Traumatol. 2015 Aug;25(6):1031-8. doi: 10.1007/s00590-015-1609-2. Epub 2015 Feb 18.

Abstract

Objectives: It is still under debate that red blood cell (RBC) transfusions might increase the risk of healthcare-associated infections after hip fracture surgery. Previously, we found that a liberal RBC transfusion strategy improved survival in nursing home residents. Our aim, therefore, was to investigate whether a more liberal RBC transfusion strategy was associated with a higher infection risk in frail elderly hip fracture patients.

Design: Prospective, assessor-blinded, randomized and controlled trial.

Settings: Orthopedic ward, Geriatric ward, and Hospital-at-home.

Patients: 284 consecutively hospital-admitted elderly with hip fracture from nursing homes or sheltered housing facilities were included.

Intervention: A restrictive RBC transfusion strategy (hemoglobin <9.7 g/dL; 6 mmol/L) compared with a liberal strategy (hemoglobin <11.3 g/dL; 7 mmol/L) administered within 30 days after surgery.

Main outcome measurements: Leukocytes and C-reactive protein (CRP) in repeated blood samples within 30 days, and number of all infections (pneumonia, urinary tract infection, and other infections) within 10 days.

Results: 88 % of the patients received a RBC transfusion. A median of 1 RBC unit (interquartile range (IQR): 1-2) was transfused for the restrictive strategy group versus 3 RBC units (IQR: 2-5) for the liberal group. Leukocytes and CRP measurements were similar for both groups. Rates of infection were 72 % for the restrictive group compared to 66 % for the liberal group (risk ratio 1.08; 95 % confidence interval 0.93-1.27, p value 0.29).

Conclusions: A more liberal RBC transfusion strategy was not associated with higher risk of infection among residents from nursing homes or sheltered housing undergoing hip fracture surgery.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • C-Reactive Protein / metabolism
  • Cross Infection / etiology*
  • Erythrocyte Transfusion / adverse effects*
  • Female
  • Frail Elderly*
  • Hip Fractures / surgery*
  • Homes for the Aged
  • Hospitalization
  • Humans
  • Leukocyte Count
  • Male
  • Nursing Homes
  • Pneumonia, Bacterial / etiology
  • Postoperative Complications / etiology*
  • Prospective Studies
  • Risk Factors
  • Surgical Wound Infection / etiology
  • Urinary Tract Infections / etiology

Substances

  • C-Reactive Protein